Michael Sherling, MD, MBA
CHIEF MEDICAL AND STRATEGY OFFICER & CO-FOUNDER
Dr. Michael Sherling is cofounder and Chief Medical and Strategy Officer of ModMed®. His personal passion aligns with the company’s mission of transforming how healthcare information is created, consumed and utilized to increase practice efficiency and patient outcomes. As a practicing physician, he knows firsthand just how important specialty-specific knowledge and workflows are, when it comes to saving time and focusing on patient care.
Michael is responsible for the strategy and medical innovation within the ModMed suite of products and services for dermatology, gastroenterology, ophthalmology, orthopedics, plastic surgery, otolaryngology and urology specialties. Under his leadership, ModMed has established a growing user base of over 15,000 providers.
Michael is a dynamic public speaker and has had the honor of presenting at various industry events including: the Association of Dermatology Administrators & Managers (ADAM) Annual Meetings since 2017, the 2016 Dermatology Entrepreneurship Conference and the 2015 Health 2.0 Conference, “Tools to Fix the Clinical User Experience.”
Michael has been a practicing dermatologist since 2006 and currently practices in a comprehensive skin care dermatology group in Palm Beach County, Florida. He is board certified by the American Board of Dermatology.
Prior to relocating to Florida, he was the Associate Director of Laser Medicine and Skin Health at Brigham and Women’s Hospital in Boston and served as the Associate Residency Program Director for Harvard Medical School’s Department of Dermatology. He has several publications in peer-reviewed medical literature.
Michael obtained his BS in Biology at Brown University with honors in 1996, his MD from Yale School of Medicine with honors in 2002 and his MBA from Yale School of Management in 2002. He received his clinical training at Harvard Medical School, where he served as chief resident in dermatology.